Literature DB >> 11121857

Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment.

Q Zhou1, T Hopp, S A Fuqua, P S Steeg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11121857     DOI： 10.1016/s0304-3835(00)00657-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


× No keyword cloud information.
  8 in total

Review 1.  Cell cycle genes in a mouse mammary hyperplasia model.

Authors:  Thenaa K Said; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

2.  Exploration of the APC/beta-catenin (WNT) pathway and a histologic classification system for pulmonary artery intimal sarcoma. A study of 18 cases.

Authors:  A Gaumann; B Bode-Lesniewska; D R Zimmermann; J C Fanburg-Smith; C J Kirkpatrick; F Hofstädter; M Woenckhaus; R Stoehr; E C Obermann; W Dietmaier; A Hartmann
Journal:  Virchows Arch       Date:  2008-09-20       Impact factor: 4.064

3.  Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.

Authors:  Yasutoshi Yamada; Hideo Hidaka; Naohiko Seki; Hirofumi Yoshino; Takeshi Yamasaki; Toshihiko Itesako; Masayuki Nakagawa; Hideki Enokida
Journal:  Cancer Sci       Date:  2012-12-29       Impact factor: 6.716

Review 4.  Clinical significance of cell cycle inhibitors in hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Masaaki Takamura; Satoshi Yamagiwa; Yutaka Aoyagi; Mami Osawa; Shun Fujimaki; Ayumi Sanpei; Takuya Genda; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2013-05-03       Impact factor: 2.309

5.  The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma.

Authors:  Reza Mehrazin; Essel Dulaimi; Robert G Uzzo; Karthik Devarjan; Jianming Pei; Marc C Smaldone; Alexander Kutikov; Joseph R Testa; Tahseen Al-Saleem
Journal:  Ther Adv Urol       Date:  2017-10-31

6.  Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.

Authors:  E S Schernhammer; G J Tranah; E Giovannucci; A T Chan; J Ma; G A Colditz; D J Hunter; W C Willett; C S Fuchs
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

7.  Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients.

Authors:  M Stendahl; A Kronblad; L Rydén; S Emdin; N O Bengtsson; G Landberg
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

8.  Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence.

Authors:  K Jirström; A Ringberg; M Fernö; L Anagnostaki; G Landberg
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.